Eribulin approval in advanced liposarcoma – successful drug or a weaker methodology?
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2017-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2017;volume=38;issue=1;spage=2;epage=3;aulast=Rastogi |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850145918179868672 |
|---|---|
| author | Sameer Rastogi Vineet Gupta |
| author_facet | Sameer Rastogi Vineet Gupta |
| author_sort | Sameer Rastogi |
| collection | DOAJ |
| format | Article |
| id | doaj-art-d67810feafb942e6b7e7f9f0aa353e05 |
| institution | OA Journals |
| issn | 0971-5851 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | Indian Journal of Medical and Paediatric Oncology |
| spelling | doaj-art-d67810feafb942e6b7e7f9f0aa353e052025-08-20T02:27:58ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58512017-01-013812310.4103/0971-5851.203492Eribulin approval in advanced liposarcoma – successful drug or a weaker methodology?Sameer RastogiVineet Guptahttp://www.ijmpo.org/article.asp?issn=0971-5851;year=2017;volume=38;issue=1;spage=2;epage=3;aulast=Rastogi |
| spellingShingle | Sameer Rastogi Vineet Gupta Eribulin approval in advanced liposarcoma – successful drug or a weaker methodology? Indian Journal of Medical and Paediatric Oncology |
| title | Eribulin approval in advanced liposarcoma – successful drug or a weaker methodology? |
| title_full | Eribulin approval in advanced liposarcoma – successful drug or a weaker methodology? |
| title_fullStr | Eribulin approval in advanced liposarcoma – successful drug or a weaker methodology? |
| title_full_unstemmed | Eribulin approval in advanced liposarcoma – successful drug or a weaker methodology? |
| title_short | Eribulin approval in advanced liposarcoma – successful drug or a weaker methodology? |
| title_sort | eribulin approval in advanced liposarcoma successful drug or a weaker methodology |
| url | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2017;volume=38;issue=1;spage=2;epage=3;aulast=Rastogi |
| work_keys_str_mv | AT sameerrastogi eribulinapprovalinadvancedliposarcomasuccessfuldrugoraweakermethodology AT vineetgupta eribulinapprovalinadvancedliposarcomasuccessfuldrugoraweakermethodology |